Source: Saxagliptin, Alogliptin Linked to Heart Failure, FDA Warns | Medpage Today
Do you know what skin cancer really looks like? … Are you sure?
Source: Tweet of the Week: What’s Your Diagnosis? | Medpage Today
Source: Constant Interruptions From Smartphones Are Lowering Productivity – Fortune
Source: Is Email Sinking the U.S. Economy? – Study Hacks – Cal Newport
For 75 years, researchers have been following a group of young people into old age. Watch what they’ve learned.
Source: Video: Lessons from the Longest Study of Health & Happiness | Senior Planet
Conclusions: Treatment with rosuvastatin at a dose of 10 mg per day resulted in a significantly lower risk of cardiovascular events than placebo in an intermediate-risk, ethnically diverse population without cardiovascular disease. (Funded by the Canadian Institutes of Health Research and AstraZeneca; HOPE-3 ClinicalTrials.gov number, NCT00468923.)
Source: Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease — NEJM
Source: Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease — NEJM
Source: Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease — NEJM
COLORADO SPRINGS, CO—Saying the turn of events will greatly benefit the 17-year-old’s economic security, sources confirmed Friday that local high school senior Emily Harrison’s failure to get into the University of Southern California, a private academic institution, will be the single most financially responsible act of her entire life. According to reports, Harrison’s rejected application, which she spent weeks preparing in hopes of spending four years at her “dream school,” will save the young student a total of nearly $370,000.
A system that piles debt on students in exchange for a marginal or even zero-return on their investment is morally and financially bankrupt.
Charles Hugh Smith
This study describes the characteristics of patients referred for typical, atypical, or no angina and examines the associations between angina type, pre–cardiac catheterization stress test results, and burden of coronary atherosclerosis identified on coronary angiography.
In this short research letter we find further lack of utility for stress tests in the manner for which we are currently using them for risk stratification. The authors categorized patients referred for catheterization without known CAD to groups based on chest pain symptoms of: typical, atypical, or absent. They then looked at their stress test results, categorized as positive or negative, and found that a negative stress test did not help predict those without obstructive CAD on catheterization. Specifically, patients with typical angina symptoms and a negative stress test were the MOST likely to have obstructive CAD (74%). Clearly limited by the nature of the data presented, and the limited information given regarding the methodology in this research letter, it does further raise doubts regarding the utility of stress testing to risk stratify patients for CAD.
HT to Jeremy Fried for the observation quoted above. Source: Research and Reviews R&R in the FastLane | LITFL: Life in the Fast Lane Medical Blog
You must be logged in to post a comment.